<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T04:53:05Z</responseDate>
  <request identifier="oai:figshare.com:article/34027415" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34027415</identifier>
        <datestamp>2026-09-29T19:12:47Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Performance
of a Group II Intron Reverse Transcriptase
from Anoxybacillus flavithermus in
Duplex RT-LAMP for SARS-CoV‑2 Detection</dc:title>
          <dc:creator>Igor P. Oscorbin (25138679)</dc:creator>
          <dc:creator>Elizaveta D. Baranova (25138682)</dc:creator>
          <dc:creator>Maxim L. Filipenko (25138685)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>optimal temperature range</dc:subject>
          <dc:subject>mediated isothermal amplification</dc:subject>
          <dc:subject>retroviral rnase h</dc:subject>
          <dc:subject>demonstrate superior thermostability</dc:subject>
          <dc:subject>deficient reverse transcriptase</dc:subject>
          <dc:subject>transcribed rna fragments</dc:subject>
          <dc:subject>reverse transcription loop</dc:subject>
          <dc:subject>58 – 98</dc:subject>
          <dc:subject>95 ° c</dc:subject>
          <dc:subject>200 negative samples</dc:subject>
          <dc:subject>lamp targeting sars</dc:subject>
          <dc:subject>reverse transcription</dc:subject>
          <dc:subject>reverse transcriptases</dc:subject>
          <dc:subject>retroviral counterparts</dc:subject>
          <dc:subject>observations demonstrate</dc:subject>
          <dc:subject>rna viruses</dc:subject>
          <dc:subject>respiratory symptoms</dc:subject>
          <dc:subject>proven advantageous</dc:subject>
          <dc:subject>may increase</dc:subject>
          <dc:subject>internal control</dc:subject>
          <dc:subject>high concentrations</dc:subject>
          <dc:subject>care diagnostics</dc:subject>
          <dc:subject>betaine increased</dc:subject>
          <dc:subject>based diagnostics</dc:subject>
          <dc:subject>anoxybacillus flavithermus</dc:subject>
          <dc:subject>89 %).</dc:subject>
          <dc:subject>15 min</dc:subject>
          <dc:description>Reverse transcriptases from bacterial group II introns
(GII RTs)
demonstrate superior thermostability and processivity compared with
retroviral counterparts. While GII RTs have proven advantageous for
RNA-seq, their performance in other applications, such as reverse
transcription loop-mediated isothermal amplification (RT-LAMP), remains
poorly studied. RT-LAMP is a widely used method suitable for point-of-care
diagnostics of RNA viruses and other pathogens. In this study, we
compared the performance in RT-LAMP of GII RT from the thermophilic
bacterium Anoxybacillus flavithermus (Afl RT) with that of the retroviral RNase H-deficient reverse transcriptase
M-MuLV. A duplex RT-LAMP targeting SARS-CoV-2 and MS2 phage genomic
RNA (internal control) served as a model. Preheating at 95 °C
and 1.5 M betaine increased the efficiency of RT-LAMP with both reverse
transcriptases. Under these conditions, the optimal temperature range
and time of reverse transcription were similar for both enzymes, 55–60
°C and 15 min, respectively. However, high concentrations of
Afl RT (&gt;50 U/reaction) inhibited RT-LAMP. Notably, RT-LAMP with
Afl
RT demonstrated higher sensitivity for detecting both in vitro-transcribed
RNA fragments and SARS-CoV-2–positive samples. In validation
against RT-qPCR using nasal swabs (200 SARS-CoV-2-positive and 200
negative samples) from patients with respiratory symptoms, the observed
sensitivity of RT-LAMP with Afl RT was 100% (200/200; 95% CI, 98.17–100%),
whereas with M-MuLV RT, sensitivity was 97.0% (194/200; 95% CI, 93.58–98.89%).
Specificity was 100% for both RTs (200/200; 95% CI, 98.17–100%).
These observations demonstrate that Afl RT is suitable for RT-LAMP
and may increase the sensitivity of LAMP-based diagnostics.</dc:description>
          <dc:date>2026-09-29T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acsinfecdis.6c00293.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Performance_of_a_Group_II_Intron_Reverse_Transcriptase_from_Anoxybacillus_flavithermus_in_Duplex_RT-LAMP_for_SARS-CoV_2_Detection/34027415</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
